James A Ottevaere Ii, MD | |
1221 Whipple St, Eau Claire, WI 54703-5270 | |
(715) 838-3311 | |
Not Available |
Full Name | James A Ottevaere Ii |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 31 Years |
Location | 1221 Whipple St, Eau Claire, Wisconsin |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356343107 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 38778 (Wisconsin) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mayo Clinic Health System Eau Claire Hospital | Eau claire, WI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mayo Clinic Health System-northwest Wisconsin Region Inc | 4385553627 | 623 |
News Archive
A study by Dana-Farber Cancer Institute researchers offers the strongest evidence yet of the effectiveness of a novel therapy for chronic graft-versus-host disease (GVHD), a potentially life-threatening complication of donor bone marrow and stem cell transplants.
A groundbreaking tumor-highlighting technology- OTL38- enhances the visualization of lung cancer tissue, providing surgeons with a significantly better chance of finding and removing more cancer than previously possible, according to a scientific presentation at the 56th Annual Meeting of The Society of Thoracic Surgeons.
In what is believed to be the most comprehensive molecular characterization to date of the most common type of head and neck cancer, researchers from the Johns Hopkins departments of pathology and oncology, the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine, and 18 other centers around the U.S. and Poland have clarified the contribution of key cancer-associated genes, proteins and signaling pathways in these cancers, while proposing possible new treatment avenues.
The number of suspected cholera cases in Yemen has reached 101,820 and killed 798 people since 27th April, says the World Health Organization (WHO).
Collaboration by American and German scientists has revealed that the sex hormone oestrogen increases a women's competitiveness.
› Verified 4 days ago
Entity Name | Mayo Clinic Health System-franciscan Medical Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629056049 PECOS PAC ID: 0345152443 Enrollment ID: O20031110000684 |
News Archive
A study by Dana-Farber Cancer Institute researchers offers the strongest evidence yet of the effectiveness of a novel therapy for chronic graft-versus-host disease (GVHD), a potentially life-threatening complication of donor bone marrow and stem cell transplants.
A groundbreaking tumor-highlighting technology- OTL38- enhances the visualization of lung cancer tissue, providing surgeons with a significantly better chance of finding and removing more cancer than previously possible, according to a scientific presentation at the 56th Annual Meeting of The Society of Thoracic Surgeons.
In what is believed to be the most comprehensive molecular characterization to date of the most common type of head and neck cancer, researchers from the Johns Hopkins departments of pathology and oncology, the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine, and 18 other centers around the U.S. and Poland have clarified the contribution of key cancer-associated genes, proteins and signaling pathways in these cancers, while proposing possible new treatment avenues.
The number of suspected cholera cases in Yemen has reached 101,820 and killed 798 people since 27th April, says the World Health Organization (WHO).
Collaboration by American and German scientists has revealed that the sex hormone oestrogen increases a women's competitiveness.
› Verified 4 days ago
Entity Name | Mayo Clinic Health System-northwest Wisconsin Region Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1235588831 PECOS PAC ID: 4385553627 Enrollment ID: O20161109002075 |
News Archive
A study by Dana-Farber Cancer Institute researchers offers the strongest evidence yet of the effectiveness of a novel therapy for chronic graft-versus-host disease (GVHD), a potentially life-threatening complication of donor bone marrow and stem cell transplants.
A groundbreaking tumor-highlighting technology- OTL38- enhances the visualization of lung cancer tissue, providing surgeons with a significantly better chance of finding and removing more cancer than previously possible, according to a scientific presentation at the 56th Annual Meeting of The Society of Thoracic Surgeons.
In what is believed to be the most comprehensive molecular characterization to date of the most common type of head and neck cancer, researchers from the Johns Hopkins departments of pathology and oncology, the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine, and 18 other centers around the U.S. and Poland have clarified the contribution of key cancer-associated genes, proteins and signaling pathways in these cancers, while proposing possible new treatment avenues.
The number of suspected cholera cases in Yemen has reached 101,820 and killed 798 people since 27th April, says the World Health Organization (WHO).
Collaboration by American and German scientists has revealed that the sex hormone oestrogen increases a women's competitiveness.
› Verified 4 days ago
Entity Name | Mayo Clinic Health System-northwest Wisconsin Region Inc |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1154372944 PECOS PAC ID: 4385553627 Enrollment ID: O20171012000001 |
News Archive
A study by Dana-Farber Cancer Institute researchers offers the strongest evidence yet of the effectiveness of a novel therapy for chronic graft-versus-host disease (GVHD), a potentially life-threatening complication of donor bone marrow and stem cell transplants.
A groundbreaking tumor-highlighting technology- OTL38- enhances the visualization of lung cancer tissue, providing surgeons with a significantly better chance of finding and removing more cancer than previously possible, according to a scientific presentation at the 56th Annual Meeting of The Society of Thoracic Surgeons.
In what is believed to be the most comprehensive molecular characterization to date of the most common type of head and neck cancer, researchers from the Johns Hopkins departments of pathology and oncology, the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine, and 18 other centers around the U.S. and Poland have clarified the contribution of key cancer-associated genes, proteins and signaling pathways in these cancers, while proposing possible new treatment avenues.
The number of suspected cholera cases in Yemen has reached 101,820 and killed 798 people since 27th April, says the World Health Organization (WHO).
Collaboration by American and German scientists has revealed that the sex hormone oestrogen increases a women's competitiveness.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
James A Ottevaere Ii, MD 200 1st St Sw, Rochester, MN 55905-0002 Ph: (715) 838-5222 | James A Ottevaere Ii, MD 1221 Whipple St, Eau Claire, WI 54703-5270 Ph: (715) 838-3311 |
News Archive
A study by Dana-Farber Cancer Institute researchers offers the strongest evidence yet of the effectiveness of a novel therapy for chronic graft-versus-host disease (GVHD), a potentially life-threatening complication of donor bone marrow and stem cell transplants.
A groundbreaking tumor-highlighting technology- OTL38- enhances the visualization of lung cancer tissue, providing surgeons with a significantly better chance of finding and removing more cancer than previously possible, according to a scientific presentation at the 56th Annual Meeting of The Society of Thoracic Surgeons.
In what is believed to be the most comprehensive molecular characterization to date of the most common type of head and neck cancer, researchers from the Johns Hopkins departments of pathology and oncology, the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine, and 18 other centers around the U.S. and Poland have clarified the contribution of key cancer-associated genes, proteins and signaling pathways in these cancers, while proposing possible new treatment avenues.
The number of suspected cholera cases in Yemen has reached 101,820 and killed 798 people since 27th April, says the World Health Organization (WHO).
Collaboration by American and German scientists has revealed that the sex hormone oestrogen increases a women's competitiveness.
› Verified 4 days ago
Michael Q Milz, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1221 Whipple St, Eau Claire, WI 54703 Phone: 715-838-3311 | |
Eric D Etzel, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1221 Whipple St, Eau Claire, WI 54703 Phone: 715-838-3311 | |
John M Evans, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1221 Whipple St, Eau Claire, WI 54703 Phone: 715-838-3311 | |
Frederick P Fetzer, DO Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2116 Craig Road, Eau Claire, WI 54701 Phone: 715-387-7179 | |
Melissa Kenevan, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1400 Bellinger St, Eau Claire, WI 54703 Phone: 715-838-5222 | |
Steven M Kapla, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1221 Whipple St, Eau Claire, WI 54703 Phone: 715-838-3311 | |
Carmelina Gurrieri, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1221 Whipple St, Eau Claire, WI 54703 Phone: 715-838-5222 |